Compare KURA & RMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KURA | RMIX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 912.7M | 772.3M |
| IPO Year | 2015 | 2026 |
| Metric | KURA | RMIX |
|---|---|---|
| Price | $8.08 | $11.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 6 |
| Target Price | ★ $31.85 | $22.50 |
| AVG Volume (30 Days) | ★ 1.6M | 583.9K |
| Earning Date | 11-10-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $42.98 | $131.09 |
| Revenue Next Year | $116.68 | $42.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $7.36 | $8.73 |
| 52 Week High | $13.90 | $25.50 |
| Indicator | KURA | RMIX |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 51.67 |
| Support Level | $8.65 | $8.73 |
| Resistance Level | $11.32 | $18.12 |
| Average True Range (ATR) | 0.54 | 0.64 |
| MACD | 0.08 | 0.34 |
| Stochastic Oscillator | 46.95 | 93.05 |
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Suncrete Inc is a ready-mix concrete logistics and distribution platform operating across Oklahoma and Arkansas. Ready-mix concrete is a crucial building material that is used in the vast majority of infrastructure, commercial and residential construction projects. The company's ready-mix concrete business engages principally in the precise formulation, efficient production and on-time delivery of ready-mix concrete to the customers' job sites. It serves substantially all end markets of the construction industry in the select geographic markets. The company earns revenue prominently from the production and delivery of ready-mix concrete, with the majority revenue generated from orders under master purchase agreements or through direct sales to third-party contractors and suppliers.